Results 171 to 180 of about 22,586,581 (189)

Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025

Leukemia and Lymphoma, 2022
Ruben Gw Quek, Wenzhen Ge, Gena Kanas
exaly  

Improving Outcomes for Patients with Diffuse Large B-cell Lymphoma†

Ca-A Cancer Journal for Clinicians, 2010
Christopher R Flowers, Julie M Vose, Rajni Sinha   +2 more
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

Journal of Experimental Medicine, 2003
Jan Delabie, Harald Holte
exaly  

Diffuse large B-cell lymphoma variants: an update

Pathology, 2020
L Jeffrey Medeiros, Narittee Sukswai, Kirill Lyapichev   +2 more
exaly  

Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma

Annals of Oncology, 2008
Bruce Cheson, B D Cheson, B Coiffier
exaly  

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

New England Journal of Medicine, 2019
Harald Holte, Ulrich Jaeger, Joseph McGuirk   +2 more
exaly  

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation

Annals of Oncology, 2008
D H Fowler, S Z Pavletič, Daniel H Fowler   +2 more
exaly  

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Andrés J M Ferreri, Markus Raderer, Barbara Kiesewetter   +2 more
exaly  

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

New England Journal of Medicine, 2002
Christian Gisselbrecht, Philippe Gaulard, Raoul Herbrecht   +2 more
exaly